The Promise of Immuno-oncology in Bladder Cancer

Bladder cancer treatments are hampered by high recurrence, requiring multiple therapeutic interventions which are highly invasive and cause side effects, underscoring the need for innovative treatments. In the pursuit of advancing bladder cancer treatment, immuno-oncology shows promise. This blog delves into the importance of identifying antigens in the development of targeted cancer therapies.  

Written by
Anna Tzani
  • Categories
  • Disease Pathophysiology
  • Target Selection
Receive the latest newsletter directly to your inbox


The Promise of Immuno-oncology

The Challenges of Bladder Cancer

Genes and Proteins Affecting Bladder Cancer

The Promise of Immuno-oncology in Bladder Cancer image 0
Figure 1: Dendrogram view of genes and proteins affecting bladder cancer.

CD117 as a Target for Bladder Cancer



More on Disease Pathophysiology